Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantation

doi:10.3748/wjg.v20.i2.414

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6392)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-5) series.

Item

Count

PDF

333

WORD

287

HTML

3537

Tables (1-5)

370

Sum=4527

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

972

Download

893

Sum=1865

Jan 14, 2014 (publication date) through Apr 11, 2025

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jan 14, 2014; 20(2): 414-424
Published online Jan 14, 2014. doi: 10.3748/wjg.v20.i2.414

Table 2 Summary of outcomes post orthotopic liver transplant in hepatitis B virus/human immunodeficiency virus co-infection

Ref.	Study period	Country	n	Median follow-up (mo)	Survival	Graft survival	Comments
Coffin et al[49]	2001-2007	United States	22	42	85% 1 yr	85% 1 yr	About 50% had detectable HBV pre transplant
Coffin et al[49]	2001-2007	United States	22	42	85% 3 yr	85% 3 yr	About 50% had detectable HBV pre transplant
Tateo et al[97]	1999-2007	France	13	32	100%	100%	1 co-infected with HDV, 2 with HCV, 4 with HCV and HDV
Anadol et al[96]	1997-2011	Germany	10	61¹	90% 1 yr	NR
Anadol et al[96]	1997-2011	Germany	10	61¹	80% 5 yr	NR
Schreibman et al[98]	1999-2006	United States	8	NR	75% 1 yr	NR	2 co-infected with HCV, 1 fulminant hepatic failure
Schreibman et al[98]	1999-2006	United States	8	NR	75% 3 yr	NR	2 co-infected with HCV, 1 fulminant hepatic failure
Norris et al[99]	1995-2003	United Kingdom	4	22	100% 1 yr	NR

¹For entire series. HBV: Hepatitis B virus; HCV: Hepatitis C virus; NR: Not reported; HDV: Hepatitis D virus.

Citation: Congly SE, Doucette KE, Coffin CS. Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantation. World J Gastroenterol 2014; 20(2): 414-424
URL: https://www.wjgnet.com/1007-9327/full/v20/i2/414.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i2.414